Biogen Pharmachem Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | -0.65 | -0.09 | 0.78 |
| Operating Expense | 0.35 | 0.07 | 0.04 |
| Net Profit | -1 | -0.16 | 0.74 |
| Net Profit Margin | 153.85 | 177.78 | 94.87 |
| Earning Per Share | -0.02 | TBA | 0.01 |
| EBIDTA | -1 | -0.16 | 0.74 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | -0.65 |
| Operating Expense | 0.35 |
| Net Profit | -1.00 |
| Net Profit Margin | 153.85 |
| Earning Per Share | -0.02 |
| EBIDTA | -1.00 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | 2.47 |
| Operating Expenses Annual | 0.45 | 0.46 | 2.49 |
| Operating Profit Annual | 1.93 | 0.46 | -0.01 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | TBA | TBA | TBA |
| Net Profit Annual | 1.93 | 0.46 | -0.01 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.45 |
| Operating Profit Annual | 1.93 |
| Interest Annual | TBA |
| Depreciation | TBA |
| Net Profit Annual | 1.93 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.13 | 0.08 | 0.01 |
| Cash Flow from Operations | 1.94 | 1.70 | 1.40 |
| Cash Flow from Investing | -2.06 | -1.66 | -1.32 |
| Cash Flow from Financing | TBA | TBA | TBA |
| Cash Flow at the End | 0.02 | 0.13 | 0.08 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.13 |
| Cash Flow from Operations | 1.94 |
| Cash Flow from Investing | -2.06 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.13 | -21.98 | -0.40 |
| PBIT Margin (%) | 15.13 | -21.98 | -0.40 |
| PBT Margin (%) | -741.17 | -21.98 | -0.40 |
| Net PROFIT Margin (%) | 81.09 | 50.55 | -0.40 |
| Return On Networth / Equity (%) | 0.52 | -0.34 | TBA |
| Return On Networth /Employed (%) | 0.55 | -0.34 | TBA |
| Return On Assets (%) | 0.81 | TBA | -0.02 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.01 | TBA | 0.05 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.13 |
| PBIT Margin (%) | 15.13 |
| PBT Margin (%) | -741.17 |
| Net PROFIT Margin (%) | 81.09 |
| Return On Networth / Equity (%) | 0.52 |
| Return On Networth /Employed (%) | 0.55 |
| Return On Assets (%) | 0.81 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | TBA |
| Total Current Assets Annual | 0.09 | 0.15 | 1.93 |
| Non Current Assets Annual | 56.73 | 54.67 | 53.02 |
| Total Shareholders Funds Annual | 56.52 | 54.59 | 54.13 |
| Total Assets Annual | 56.82 | 54.83 | 54.95 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | 0.09 |
| Non Current Assets Annual | 56.73 |
| Total Shareholders Funds Annual | 56.52 |
| Total Assets Annual | 56.82 |
No Data Availabe
